GEISTWERT Rechtsanwälte Lawyers Avvocati

ORD_15496/2025

Ascendis Pharma Growth Disorders A/S, Ascendis Pharma A/S v. BioMarin Pharmaceutical Inc.

Datum
2025-04-02
Kammer
Munich (DE) Local Division
Verfahrensart
Preliminary objection
Sprache
EN

Metadaten

Fall-IDORD_15496-2025-d4a8ea792e7e
Aktenzeichen
RegisterzeichenORD_15496/2025
EntscheidungsreferenzORD_15496/2025
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 4

Procedural Order of the Court of First Instance of the Unified Patent Court Local Division Munich issued on 2 April 2025 CLAIMANT 1) BioMarin Pharmaceutical Inc. 105 Digital Drive - CA 94949 - Novato - US represented by: Dr. Christian Paul, Dr. Tobias Mandler, Pascal Grandé, Dr. Olga Bezzubova, Dr. Ping Li, Dr. Sven Rihm (JONES DAY) supported by: Jason Raeburn, Alex Morgan (PAUL HASTINGS) DEFENDANTS 1) Ascendis Pharma A/S Tuborg Boulevard 12 - 2900 - Hellerup - DK 2) Ascendis Pharma Growth Disorders A/S Tuborg Boulevard 12 - 2900 - Hellerup - DK represented by: Agathe Michel-de Cazotte, Anna Leathley, Daniel Wiese (Carpmaels & Ransford) PATENT AT ISSUE European patent n° 3 175 863 PANEL/DIVISION Panel 1 of the Local Division Munich DECIDING JUDGE/S This order has been issued by the Presidi ...